English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNew research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual scientific meeting, found that the recommended weight-based or non-weight-based dose of hydroxychloroquine led to more hospitalizations for flares among patients with systemic lupus erythematosus
Tag: Systemic Lupus Erythematosus (SLE)
New Analysis Finds Belimumab Improves Cutaneous Lupus Erythematosus in Patients with or without SLE
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not patients also had systemic lupus erythematosus (SLE or lupus).
Study Finds Lower Risk of Severe Infection and Hospitalization with Belimumab Compared to Oral Immunosuppressants
New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the biologic B-cell inhibitor belimumab was associated with a lower risk of severe infections and hospitalizations compared to nonbiologic immunosuppressants.
Pathway uncovered for greatest lupus genetic risk factor, study shows
Researchers at Michigan Medicine have uncovered the enigmatic mechanism that genetically predisposes people to the worst effects of the most typical form of lupus, a study suggests. Researchers say the findings could potentially facilitate the discovery of safe, simple and effective treatments.